Qube Research & Technologies (QRT)
ALXO icon

Qube Research & Technologies (QRT)’s ALX Oncology ALXO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-107,647
Closed -$216K – 3430
2026
Q1 		$216K Buy
+107,647
New +$205K ﹤0.01% 2937
2025
Q4 		– Sell
-16,946
Closed -$31K – 3649
2025
Q3 		$31K Sell
16,946
-27,187
-62% -$23.5K ﹤0.01% 3244
2025
Q2 		$18.3K Sell
44,133
-102,844
-70% -$51.9K ﹤0.01% 3263
2025
Q1 		$91.6K Buy
146,977
+8,507
+6% +$10.2K ﹤0.01% 3015
2024
Q4 		$231K Sell
138,470
-319,247
-70% -$491K ﹤0.01% 2797
2024
Q3 		$833K Buy
457,717
+457,146
+80,061% +$1.7M ﹤0.01% 2094
2024
Q2 		$3.44K Buy
+571
New +$7.02K ﹤0.01% 3107
2022
Q4 		– Sell
-19,686
Closed -$188K – 2432
2022
Q3 		$188K Sell
19,686
-66,412
-77% -$774K ﹤0.01% 1794
2022
Q2 		$697K Buy
+86,098
New +$938K 0.01% 1276
2022
Q1 		– Sell
-19,190
Closed -$412K – 2410
2021
Q4 		$412K Buy
+19,190
New +$828K ﹤0.01% 1650

Other funds holding ALXO

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
venBio Partners
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Redmile Group
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.65% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALXO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of ALX Oncology (ALXO) in Q2 2026, closing a stake of 107,647 shares — an estimated $216K sold.

Qube Research & Technologies (QRT) first reported a position in ALXO in Q4 2021 and held it in 10 quarters. The position peaked at $833K in Q3 2024. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining ALX Oncology position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 107,647 ALX Oncology shares in Q2 2026, an estimated $216K.
  • Qube Research & Technologies (QRT) first reported a position in ALX Oncology in Q4 2021 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s ALX Oncology position peaked at $833K in Q3 2024.
  • 93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.